These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 6983297)

  • 21. Stability of nicardipine hydrochloride in intravenous solutions.
    Baaske DM; DeMay JF; Latona CA; Mirmira S; Sigvardson KW
    Am J Health Syst Pharm; 1996 Jul; 53(14):1701-5. PubMed ID: 8827237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin sodium solubility in three intravenous solutions.
    Pfeifle CE; Adler DS; Gannaway WL
    Am J Hosp Pharm; 1981 Mar; 38(3):358-62. PubMed ID: 7223749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: stability with common intravenous fluids.
    Gardella LA; Zaroslinski JF; Possley LH
    Am J Hosp Pharm; 1975 Jun; 32(6):575-8. PubMed ID: 239594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of milrinone in 0.45% sodium chloride, 0.9% sodium chloride, or 5% dextrose injections.
    Wilson TD; Forde MD; Crain AV; Dombrowski LJ; Joyce MA
    Am J Hosp Pharm; 1986 Sep; 43(9):2218-20. PubMed ID: 3766576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of dobutamine hydrochloride in selected large-volume parenterals.
    Kirschenbaum HL; Aronoff W; Perentesis GP; Piltz GW; Goldberg RJ; Cutie AJ
    Am J Hosp Pharm; 1982 Nov; 39(11):1923-5. PubMed ID: 7148861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of nitroglycerin in intravenous admixtures.
    Klamerus KJ; Ueda CT; Newton DW
    Am J Hosp Pharm; 1984 Feb; 41(2):303-5. PubMed ID: 6422753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions.
    Cheung YW; Cradock JC; Vishnuvajjala BR; Flora KP
    Am J Hosp Pharm; 1987 Jan; 44(1):124-30. PubMed ID: 3548341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection.
    Ptachcinski RJ; Logue LW; Burckart GJ; Venkataramanan R
    Am J Hosp Pharm; 1986 Jan; 43(1):94-7. PubMed ID: 3953588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of anthracycline antitumor agents in four infusion fluids.
    Poochikian GK; Cradock JC; Flora KP
    Am J Hosp Pharm; 1981 Apr; 38(4):483-6. PubMed ID: 6945043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
    Johnson CE; Cohen IA; Craft DA; Lizer MH
    Am J Hosp Pharm; 1986 Jun; 43(6):1482-5. PubMed ID: 3524206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection.
    Lee DK; Lee A; Wang DP
    Am J Hosp Pharm; 1991 Jan; 48(1):108-10. PubMed ID: 2000865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5% dextrose injections.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1984 Apr; 41(4):686-9. PubMed ID: 6720710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of zidovudine in 5% dextrose injection and 0.9% sodium chloride injection.
    Lam NP; Kennedy PE; Jarosinski PF; Gallelli JF
    Am J Hosp Pharm; 1991 Feb; 48(2):280-2. PubMed ID: 2003500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
    De NC; Alam AS; Kapoor JN
    Am J Hosp Pharm; 1986 Jun; 43(6):1486-8. PubMed ID: 3728484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
    Patel JP; Tran LT; Sinai WJ; Carr LJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1511-4. PubMed ID: 1882883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.
    Cloyd JC; Bosch DE; Sawchuk RJ
    Am J Hosp Pharm; 1978 Jan; 35(1):45-8. PubMed ID: 623117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
    Inagaki K; Gill MA; Okamoto MP; Takagi J
    J Parenter Sci Technol; 1993; 47(1):35-9. PubMed ID: 8445498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.